LP SD ONE HUNDRED TWENTY ONE LIMITED
Executive Summary
LP SD ONE HUNDRED TWENTY ONE LIMITED currently functions as a dormant entity strategically positioned within the specialised chemist retail sector, backed by major industry players including Lloyds Pharmacy. Its principal value lies in its ownership structure and regulatory classification, offering a platform for future market entry or expansion. To capitalize on growth potential, the company should transition from dormancy, leveraging parent company capabilities for operational scale while proactively managing regulatory compliance and market competition risks.
View Full Analysis Report →Company Documents
Date | Description |
---|---|
04/08/254 August 2025 New | Registration of charge 150751160001, created on 2025-07-31 |
04/08/254 August 2025 New | Registration of charge 150751160003, created on 2025-07-31 |
04/08/254 August 2025 New | Registration of charge 150751160002, created on 2025-07-31 |
01/08/251 August 2025 New | Termination of appointment of Qammar Nazir as a director on 2025-07-31 |
01/08/251 August 2025 New | Registered office address changed from 1 Hardman Street Spinningfields Manchester Greater Manchester M3 3HF United Kingdom to 5 Vernon Street 5 Vernon Street Derby DE1 1FR on 2025-08-01 |
01/08/251 August 2025 New | Appointment of Mr Chee Pui Lim as a director on 2025-08-01 |
01/08/251 August 2025 New | Appointment of Mr Shing Sun Leung as a director on 2025-08-01 |
01/08/251 August 2025 New | Notification of Forest Pharmaceutical Ltd as a person with significant control on 2025-08-01 |
01/08/251 August 2025 New | Cessation of Aqa Group Ltd as a person with significant control on 2025-07-31 |
25/07/2525 July 2025 New | Change of details for Aqa Group Ltd as a person with significant control on 2025-07-25 |
24/07/2524 July 2025 New | Registered office address changed from Ams Accountants Medical Limited Floor 2 9 Portland Street Manchester M1 3BE United Kingdom to 1 Hardman Street Spinningfields Manchester Greater Manchester M3 3HF on 2025-07-24 |
24/07/2524 July 2025 New | Director's details changed for Mr Qammar Nazir on 2025-07-24 |
09/04/259 April 2025 | Previous accounting period extended from 2024-09-30 to 2025-01-31 |
19/11/2419 November 2024 | Second filing of Confirmation Statement dated 2023-11-14 |
19/11/2419 November 2024 | Confirmation statement made on 2024-11-14 with no updates |
19/11/2419 November 2024 | Notification of Aqa Group Ltd as a person with significant control on 2023-10-27 |
19/11/2419 November 2024 | Cessation of Ascent Wellfield Group Ltd as a person with significant control on 2023-10-27 |
11/11/2411 November 2024 | Accounts for a dormant company made up to 2023-09-30 |
07/11/247 November 2024 | Current accounting period shortened from 2024-08-31 to 2023-09-30 |
14/11/2314 November 2023 | Termination of appointment of Dominik Mueser as a director on 2023-10-27 |
14/11/2314 November 2023 | Cessation of Lloyds Pharmacy Limited as a person with significant control on 2023-10-27 |
14/11/2314 November 2023 | Termination of appointment of Wendy Margaret Hall as a director on 2023-10-27 |
14/11/2314 November 2023 | Registered office address changed from Sapphire Court Walsgrave Triangle Coventry CV2 2TX United Kingdom to Ams Accountants Medical Limited Floor 2 9 Portland Street Manchester M1 3BE on 2023-11-14 |
14/11/2314 November 2023 | Confirmation statement made on 2023-11-14 with updates |
14/11/2314 November 2023 | Notification of Ascent Wellfield Group Ltd as a person with significant control on 2023-10-27 |
14/11/2314 November 2023 | Appointment of Mr Qammar Nazir as a director on 2023-10-27 |
30/09/2330 September 2023 | Annual accounts for year ending 30 Sep 2023 |
16/08/2316 August 2023 | Incorporation |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company